Overview
| Research | Process | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | |||
|---|---|---|---|---|---|---|---|---|
| ALT-P1 | Long-acting Human Growth Hormone |  |
|
|
|
|
||
| Domestic Phase II in Progress / Preparation of global Phase II | ||||||||
| ALT-Q2 | Long-acting Factor Vlla | |
|
|||||
| Process Development in Progress | ||||||||
| ALT-P7 | Breast/Gastric Cancer ADC | |
|
|
|
|||
| Preparation of Phase II Clinical Trial | ||||||||
| ALT-Q5 | Ovarian Cancer ADC | |
|
|||||
| Process Development in Progress | ||||||||
| ALT-L9 | Eylea Biosimilar | |
|
|
|
|||
| First-in-class Domestic Phase I Clinical Trial in Progress | ||||||||
| ALT-L2 | Herceptin Biosimilar | |
|
|
|
|
||
| Preparation of Global Phase III Clinical Trial | ||||||||
| ALT-LS2 | Herceptin SC Biosimilar | |
|
|||||
| Process Development in Progress | ||||||||
